Skip to main content
OpenTrials
Completed

NCT Number: NCT03455595

CONECCT (Colorectal Neoplasia Endoscopic Classification To Chose the Endoscopic Treatment)

Prospective study so as to evaluate CONECCT score to determine both histological tissue and therapeutic choice

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Edouard Herriot Hospital

Lyon, Auvergne-Rhône-Alpes, 69437, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • N/A

Exclusion criteria

  • N/A

Treatment and study plan

Endoscopic exams

Procedure

Coloscopy

Primary outcomes

  1. Evaluation of the CONECCT endoscopic score so as to improve colon therapeutic treatment polyps

    Time frame: one year

    There are recognized diagnostic criteria so as to predict the histology of colorectal lesions and thus to choose the right therapy. For the moment, these criteria are scattered in at least 5 different classifications and the CONECCT tool will allow gastroenterology interns to more easily predict the histology of the lesion and so to improve the management of them.

Sponsors and collaborators

Lead sponsor

Hôpital Edouard Herriot

Other

Registry information

Official study title

CONECCT Score so as to Improve the Diagnosis and the Treatment of Colorectal Neoplasia

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Mar 6, 2018
Registry last updated
Mar 12, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.